Identification of (R)-[18F]YH134 for Monoacylglycerol Lipase Neuroimaging and Exploration of Its Use for Central Nervous System and Peripheral Drug Development


METADATA ONLY
Loading...

Date

2024-02

Publication Type

Journal Article

ETH Bibliography

yes

Citations

Web of Science:
Scopus:
Altmetric
METADATA ONLY

Data

Rights / License

Abstract

This study aimed to evaluate (R)-[18F]YH134 as a novel PET tracer for imaging monoacylglycerol lipase (MAGL). Considering the ubiquitous expression of MAGL throughout the whole body, the impact of various MAGL inhibitors on (R)-[18F]YH134 brain uptake and its application in brain–periphery crosstalk were explored. Methods: MAGL knockout and wild-type mice were used to evaluate (R)-[18F]YH134 in in vitro autoradiography and PET experiments. To explore the impact of peripheral MAGL occupancy on (R)-[18F]YH134 brain uptake, PET kinetics with an arterial input function were studied in male Wistar rats under baseline and blocking conditions. Results: In in vitro autoradi ography, (R)-[18F]YH134 revealed a heterogeneous distribution pat tern with high binding to MAGL-rich brain regions in wild-type mouse brain slices, whereas the radioactive signal was negligible in MAGL knockout mouse brain slices. The in vivo brain PET images of (R)-[18F]YH134 in wild-type and MAGL knockout mice demonstrated its high specificity and selectivity in mouse brain. A Logan plot with plasma input function was applied to estimate the distribution volume (VT) of (R)-[18F]YH134. VT was significantly reduced by a brain penetrant MAGL inhibitor but was unchanged by a peripherally restricted MAGL inhibitor. The MAGL target occupancy in the periph ery was estimated using (R)-[18F]YH134 PET imaging data from the brain. Conclusion: (R)-[18F]YH134 is a highly specific and selective PET tracer with favorable kinetic properties for imaging MAGL in rodent brain. Our results showed that blocking of the peripheral target influences brain uptake but not the VT of (R)-[18F]YH134. (R)-[18F]YH134 can be used for estimating the dose of MAGL inhibitor at half-maximal peripheral target occupancy.

Publication status

published

Editor

Book title

Volume

65 (2)

Pages / Article No.

300 - 305

Publisher

Society of Nuclear Medicine

Event

Edition / version

Methods

Software

Geographic location

Date collected

Date created

Subject

Monoacylglycerol lipase; PET imaging; Plasma input function; Drug occupancy studies

Organisational unit

03688 - Schibli, Roger / Schibli, Roger check_circle
08830 - Krämer, Stefanie (Tit.-Prof.)

Notes

Funding

Related publications and datasets